×
About 601 results

ALLMedicine™ Pediatric Atopic Dermatitis Center

Research & Reviews  263 results

Comparative effectiveness of probiotic strains on the prevention of pediatric atopic de...
https://doi.org/10.1111/pai.13514
Pediatric Allergy and Immunology : Official Publication O... Tan-Lim CSC, Esteban-Ipac NAR et. al.

Apr 3rd, 2021 - Atopic dermatitis is the most common chronic skin disease affecting the pediatric population. Probiotics has been proposed to be effective in preventing the development of pediatric atopic dermatitis. Although studies show promise for the use of p...

Association of pediatric atopic dermatitis and psoriasis with school absenteeism and pa...
https://doi.org/10.1016/j.jaad.2021.02.069
Journal of the American Academy of Dermatology; Cheng BT, Silverberg JI

Mar 5th, 2021 - The impact of childhood atopic dermatitis (AD) and psoriasis on school absenteeism is not fully elucidated. To determine the burden and predictors of chronic school absenteeism in children with AD and psoriasis. Data were analyzed from the 1999-20...

Improving patient education for atopic dermatitis: A randomized controlled trial of a c...
https://doi.org/10.1111/pde.14519
Pediatric Dermatology; LeBovidge JS, Timmons K et. al.

Jan 24th, 2021 - Patient education is important to families' ability to manage and cope with pediatric atopic dermatitis (AD). We evaluated whether an educational handbook could improve AD symptoms, caregiver confidence in AD management skills, and AD-related qual...

Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis.
https://doi.org/10.1097/DER.0000000000000690
Dermatitis : Contact, Atopic, Occupational, Drug; Ludwig CM, Hsiao JL et. al.

Dec 4th, 2020 - Dupilumab has recently been approved by the Food and Drug Administration for use for treatment of moderate to severe atopic dermatitis in children aged 6 to 11 years. It presents a novel treatment option with a favorable safety profile for patient...

Update on pediatric atopic dermatitis.
https://doi.org/10.12788/cutis.0077
Cutis Tracy A, Bhatti S et. al.

Oct 26th, 2020 - Recent studies have led to new insights into atopic dermatitis (AD) pathogenesis and epidemiology as well as its impact on the quality of life of affected children and adolescents. In addition, there are several novel topical and systemic agents r...

see more →

Clinicaltrials.gov  277 results

Comparative effectiveness of probiotic strains on the prevention of pediatric atopic de...
https://doi.org/10.1111/pai.13514
Pediatric Allergy and Immunology : Official Publication O... Tan-Lim CSC, Esteban-Ipac NAR et. al.

Apr 3rd, 2021 - Atopic dermatitis is the most common chronic skin disease affecting the pediatric population. Probiotics has been proposed to be effective in preventing the development of pediatric atopic dermatitis. Although studies show promise for the use of p...

Fast Five Quiz: Severe Pediatric Atopic Dermatitis
https://reference.medscape.com/viewarticle/944893

Mar 14th, 2021 - Atopic dermatitis, often called atopic eczema, is a chronic, pruritic inflammatory skin condition that typically affects the face (cheeks), neck, arms, and legs but usually spares the groin and axillary regions. It is common worldwide, affecting u...

Association of pediatric atopic dermatitis and psoriasis with school absenteeism and pa...
https://doi.org/10.1016/j.jaad.2021.02.069
Journal of the American Academy of Dermatology; Cheng BT, Silverberg JI

Mar 5th, 2021 - The impact of childhood atopic dermatitis (AD) and psoriasis on school absenteeism is not fully elucidated. To determine the burden and predictors of chronic school absenteeism in children with AD and psoriasis. Data were analyzed from the 1999-20...

Improving patient education for atopic dermatitis: A randomized controlled trial of a c...
https://doi.org/10.1111/pde.14519
Pediatric Dermatology; LeBovidge JS, Timmons K et. al.

Jan 24th, 2021 - Patient education is important to families' ability to manage and cope with pediatric atopic dermatitis (AD). We evaluated whether an educational handbook could improve AD symptoms, caregiver confidence in AD management skills, and AD-related qual...

Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis.
https://doi.org/10.1097/DER.0000000000000690
Dermatitis : Contact, Atopic, Occupational, Drug; Ludwig CM, Hsiao JL et. al.

Dec 4th, 2020 - Dupilumab has recently been approved by the Food and Drug Administration for use for treatment of moderate to severe atopic dermatitis in children aged 6 to 11 years. It presents a novel treatment option with a favorable safety profile for patient...

see more →

News  61 results

Fast Five Quiz: Severe Pediatric Atopic Dermatitis
https://reference.medscape.com/viewarticle/944893

Mar 14th, 2021 - Atopic dermatitis, often called atopic eczema, is a chronic, pruritic inflammatory skin condition that typically affects the face (cheeks), neck, arms, and legs but usually spares the groin and axillary regions. It is common worldwide, affecting u...

New topicals coming for pediatric atopic dermatitis
https://www.mdedge.com/clinicianreviews/article/219636/atopic-dermatitis/new-topicals-coming-pediatric-atopic-dermatitis?channel=53
Bruce Jancin

Mar 26th, 2020 - LAHAINA, HAWAII – Novel topical medications are in the works that will address the longstanding unmet need for a Food and Drug Administration–approved noncorticosteroid topical for use in pediatric atopic dermatitis, Lawrence F. Eichenfield, MD, r.

Frequent soaks ease pediatric atopic dermatitis
https://www.mdedge.com/clinicianreviews/article/214329/atopic-dermatitis/frequent-soaks-ease-pediatric-atopic-dermatitis?channel=203
Heidi Splete

Dec 14th, 2019 - A regimen of twice-daily baths followed by occlusive moisturizer improved atopic dermatitis in children with moderate to severe disease more effectively than did a twice-weekly protocol, based on data from 42 children. Guidelines for bathing frequ.

Omalizumab proves effective for severe pediatric atopic dermatitis
https://www.mdedge.com/clinicianreviews/article/212984/atopic-dermatitis/omalizumab-proves-effective-severe-pediatric?channel=203
Steve Cimino

Nov 25th, 2019 - A new study has found that omalizumab (Xolair) reduced severity and improved quality of life in pediatric patients with severe atopic dermatitis. Michail_Petrov-96/Thinkstock “Future work with an even larger sample size, a longer duration, and hig.

Cephalosporins remain empiric therapy for skin infections in pediatric AD
https://www.mdedge.com/pediatrics/article/207372/dermatology/cephalosporins-remain-empiric-therapy-skin-infections?channel=189
Steve Cimino

Sep 2nd, 2019 - A new study has reaffirmed that, as methicillin‐sensitive Staphylococcus aureus (MSSA) remains the most common skin infection in pediatric atopic dermatitis (AD) patients, first‐generation cephalosporins remain the appropriate empiric therapy. “Cl.

see more →